Published in TB and Outbreaks Week, October 29th, 2002
Dr. Juan Arroyo, Acambis' project leader for ChimeriVax-West Nile, gave a presentation on the development of the ChimeriVax-West Nile vaccine, providing data showing that, in preclinical mammalian models, the vaccine was safe and induced high levels of neutralizing antibodies. The preclinical trials also demonstrated the ability of ChimeriVax-West Nile to protect against challenge with wild-type West Nile virus.
West Nile virus is transmitted to humans by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week